Merck & Co.: Evaluating a Drug Licensing Opportunity Harvard Case Solution & Analysis

This evaluation examines the possibility to license the compound before it enters clinical trials. Description of the solutions of Merck tree evaluation process are presented. The information required to evaluate specific features of licensing is provided, including the cost of the three phases of the review process, the income in the event of approval, and the probability of various outcomes. It includes an introduction to decision tree analysis and evaluation. "Hide
by Richard S. Ruback, David Krieger Source: HBS Premier Case Collection 6 pages. Publication Date: October 30, 2000. Prod. # 201 023-PDF-ENG

Merck & Co.: Evaluating a Drug Licensing Opportunity Case Solution Other Similar Case Solutions like

Merck & Co.: Evaluating a Drug Licensing Opportunity

Share This